Investor Centre

Summit is publicly-listed in the US (NASDAQ)

News

Summit Therapeutics Reports Financial Results for the Fourth Period and Eleven Months Ended December 31, 2019, and Operational Progress
VIEW NEWS
Summit Appoints Robert W. Duggan as Chief Executive Officer
VIEW NEWS